Status:
RECRUITING
The C-BRIDGE Study: China Bronchiectasis Research Involving Databases, Genomics, and Endotyping
Lead Sponsor:
Shanghai Pulmonary Hospital, Shanghai, China
Conditions:
Bronchiectasis Adult
Eligibility:
All Genders
18-85 years
Brief Summary
Bronchiectasis is a heterogeneous airway disease with diverse causes, making precise diagnosis, prognosis, and treatment response prediction challenging. Identifying patient subgroups (phenotypes) and...
Detailed Description
Bronchiectasis is a common, heterogeneous chronic airway disease that remains understudied in clinical and translational research. Although several phenotypes and endotypes have been identified-primar...
Eligibility Criteria
Inclusion
- A prior CT scan confirming bronchiectasis, accompanied by a compatible clinical syndrome including cough, sputum production, and/or recurrent respiratory tract infections.
- At the screening visit, participants must have been clinically stable for 4 weeks, defined as no antibiotic or corticosteroid treatment for a pulmonary exacerbation in the preceding 4 weeks.
Exclusion
- Inability to provide informed consent
- Age under 18 years
- Patients with active tuberculosis
- Use of antibiotics or corticosteroids for a pulmonary exacerbation within the past 4 weeks
Key Trial Info
Start Date :
April 6 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2029
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT06900062
Start Date
April 6 2025
End Date
January 31 2029
Last Update
November 25 2025
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Lin Liu
Guiyang, Guizhou, China
2
Lei Song
Changchun, Jilin, China
3
Qian Qi
Jinan, Shangdong, China
4
He-feng Chen
Shanghai, Shanghai Municipality, China, 200433